These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23822948)

  • 1. Hyperhomocysteinemia as a consequence of life style among patients suffering from thromboangiitis obliterans.
    Fazeli B; Ravari H
    Int Angiol; 2013 Aug; 32(4):442-3. PubMed ID: 23822948
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations Between Elevated Plasma Total Homocysteine Level and Risk of Thromboangiitis Obliterans in a Chinese Population: A Matched Case-Control Study.
    Rong D; Lu W; Ge Y; Liu J; Sun G; Liu F; Xiong J; Jia X; Zhang H; Ma X; Liu X; Guo W
    Ann Vasc Surg; 2020 Jan; 62():335-341. PubMed ID: 31472234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three cases of Buerger's disease associated with hyperhomocysteinemia.
    Caramaschi P; Biasi D; Carletto A; Friso S; Girelli D; Arcaro G; Bambara LM
    Clin Exp Rheumatol; 2000; 18(2):264-5. PubMed ID: 10812506
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboangiitis obliterans (Buerger's disease).
    Diehm C; Stammler F
    N Engl J Med; 2001 Jan; 344(3):230-1. PubMed ID: 11188842
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboangiitis obliterans (Buerger's disease).
    Fiessinger JN
    Rev Rhum Engl Ed; 1997 May; 64(5):281-2. PubMed ID: 9189999
    [No Abstract]   [Full Text] [Related]  

  • 7. [The prevalence of hyperhomocysteinemia in thromboangiitis obliterans. Does homocysteine play a role pathogenetically?].
    Stammler F; Diehm C; Hsu E; Stockinger K; Amendt K
    Dtsch Med Wochenschr; 1996 Nov; 121(46):1417-23. PubMed ID: 8974873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine in occlusive vascular disease: a risk marker or risk factor.
    Bhargava S; Ali A; Manocha A; Kankra M; Das S; Srivastava LM
    Indian J Biochem Biophys; 2012 Dec; 49(6):414-20. PubMed ID: 23350275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Need for changes in clinical criteria for diagnosing Buerger's disease.
    Fazeli B
    Vascular; 2013 Apr; 21(2):117-8. PubMed ID: 23596184
    [No Abstract]   [Full Text] [Related]  

  • 10. Buerger disease (thromboangiitis obliterans): a clinical diagnosis.
    Highlander P; Southerland CC; VonHerbulis E; Gonzalez A
    Adv Skin Wound Care; 2011 Jan; 24(1):15-7. PubMed ID: 21173586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting cerebral thromboangiitis obliterans.
    Hurelbrink CB; Barnett Y; Buckland ME; Wilkinson M; Leicester J; Anderson C; Brennan J; Barnett M
    J Neurol Sci; 2012 Jun; 317(1-2):141-5. PubMed ID: 22502946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboangiitis obliterans. An update on Buerger's disease.
    Szuba A; Cooke JP
    West J Med; 1998 Apr; 168(4):255-60. PubMed ID: 9584663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients.
    Fekih-Mrissa N; Mrad M; Klai S; Mansour M; Nsiri B; Gritli N; Mrissa R
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):465-9. PubMed ID: 23642756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboangiitis obliterans (Buerger's disease).
    Olin JW
    N Engl J Med; 2000 Sep; 343(12):864-9. PubMed ID: 10995867
    [No Abstract]   [Full Text] [Related]  

  • 15. Homocysteine and "Buerger's disease".
    Courtney PA; Sharpe PC; Lee RJ
    Postgrad Med J; 2002 Aug; 78(922):500, 504-5. PubMed ID: 12185232
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thromboangiitis obliterans--an often overlooked disease with increasing incidence].
    Wahlberg E; Olofsson P; Fagrell B
    Lakartidningen; 1992 Sep; 89(37):2925-8. PubMed ID: 1405892
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary tobacco alkaloid measurement in patients having thromboangiitis obliterans.
    Hurt RD; Hays JT
    Mayo Clin Proc; 2008 Oct; 83(10):1187-8; author reply 1188. PubMed ID: 18828981
    [No Abstract]   [Full Text] [Related]  

  • 18. Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.
    Dellalibera-Joviliano R; Jacob-Ferreira AL; Joviliano EE; Tanus-Santos JE; Evora PR
    Vasc Med; 2012 Apr; 17(2):73-8. PubMed ID: 22402936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and Buerger's disease.
    Umasankar U; Huwez F
    Postgrad Med J; 2002 Dec; 78(926):764; author reply 764. PubMed ID: 12509706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.